Traditionally, SS can be distinguished into primary and secondary disease: the primary disease can be diagnosed in a patient with sicca syndrome in the absence of other underlying rheumatic diseases, and is often associated with anti-Ro/SS-A and anti-La/SSB autoantibodies. Here, CALR is linked to synovial sarcoma.